Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. Cash Flow 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Cash Flow | -149.2M | -200.3M | -237.7M | -220.5M | -184.8M | -115.1M | -137.3M | -44.7M |
| Depreciation & Amort. | 12.4M | 13.6M | 14.2M | 14.3M | 10.5M | 7.4M | 4.6M | 1.0M |
| Investing Activities | ||||||||
| Capital Expenditure | 386,000 | 694,000 | 1.5M | 5.2M | 21.4M | 66.0M | 50.8M | 3.2M |
| Free Cash Flow | -149.6M | -201.0M | -239.2M | -225.7M | -206.3M | -181.1M | -188.1M | -47.9M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — |
Allogene Therapeutics Inc. Cash Flow — FAQ
Allogene Therapeutics Inc. (ALLO) cash flow over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALLO's cash flow history?
The chart and table above show Allogene Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.